When we think of fungal infections, we often picture superficial conditions like athlete’s foot or ringworm. But there exists a far more serious category of fungal diseases that can invade deep into the body, affecting vital organs like the lungs, brain, and liver. These are called systemic mycoses, and they represent a hidden threat, particularly for people with weakened immune systems.
Systemic mycoses are fungal infections affecting internal organs. Unlike superficial fungal infections that stay on the skin’s surface, these fungi enter the body through the respiratory tract and can spread via the bloodstream to multiple organs. What makes systemic mycoses particularly challenging is that most of these infections originate from soil-dwelling fungi that people inhale without even realizing it.
Table of Contents
- Where do these infections come from?
- Understanding cryptococcosis
- The pigeon connection
- How cryptococcosis affects the body
- Histoplasmosis: the tuberculosis mimic
- Environmental sources
- How histoplasmosis attacks the body
- The tuberculosis similarity
- Why are systemic mycoses rare in India?
- The importance of early recognition
Where do these infections come from?
Most systemic mycoses begin when a person inhales fungal spores from contaminated soil or dust. These fungi are present in soils contaminated with droppings of birds, bats, and pigeons. The fungi exist harmlessly in the environment as molds, but when their spores enter the human body and encounter body temperature, they transform into a different form that can cause disease.
In healthy individuals with strong immune systems, the body’s defenses usually control these infections before symptoms develop. However, people with compromised immunity-such as those with HIV/AIDS, cancer patients, organ transplant recipients, or individuals on long-term steroid therapy-face significantly higher risks of developing serious systemic infections.
Understanding cryptococcosis
Cryptococcosis is one of the most serious systemic mycoses, caused by an encapsulated yeast called Cryptococcus neoformans. This fungal infection usually affects the lungs or brain, with people who have HIV/AIDS at particularly high risk.
The pigeon connection
What makes cryptococcosis unique is its strong association with bird droppings, especially from pigeons. Cryptococcus neoformans is commonly found in soil contaminated with pigeon and other bird droppings. The fungus thrives in this environment, and when the dried droppings are disturbed, microscopic spores become airborne and can be inhaled.
This environmental distribution means that people who work in occupations involving bird exposure-such as poultry workers, building maintenance staff cleaning roosting areas, or even those renovating old structures where pigeons have nested-face elevated risks.
How cryptococcosis affects the body
The infection typically begins in the lungs after inhalation of fungal spores. In many cases, the infection spreads through the bloodstream to infect the brain, affecting both the meninges and brain tissue, causing meningitis and meningoencephalitis. This makes cryptococcal meningitis one of the most feared complications.
Symptoms of cryptococcosis vary depending on which organs are affected. Lung infection may cause fever, cough, and chest pain. When the infection reaches the brain, patients develop severe headaches, confusion, blurred vision, and neck stiffness. Without prompt treatment, cryptococcal meningitis can be fatal.
The disease is particularly devastating in sub-Saharan Africa and other regions where HIV is prevalent. Cryptococcosis causes approximately 220,000 cases of meningitis annually among people with HIV/AIDS worldwide, resulting in 181,000 deaths each year.
Histoplasmosis: the tuberculosis mimic
Histoplasmosis, caused by the fungus Histoplasma capsulatum, presents one of medicine’s great diagnostic challenges because its symptoms so closely resemble tuberculosis. This dimorphic fungus is an intracellular organism that parasitizes the reticuloendothelial system, affecting organs rich in immune cells like the liver, spleen, lymph nodes, and bone marrow.
Environmental sources
Like cryptococcosis, histoplasmosis has a clear environmental source. The fungus is found in soil, decomposing organic matter, and in the droppings of bats and some birds such as chickens, turkeys, pigeons, and geese. Activities that disturb contaminated soil-such as exploring caves where bats live, demolishing old buildings, or working in chicken coops-can create clouds of infectious spores.
How histoplasmosis attacks the body
After inhalation, the fungal spores are deposited in the lungs’ air sacs. The spores transform into yeast forms that are then engulfed by macrophages-the immune cells meant to destroy invaders. But here’s where Histoplasma shows its cunning: instead of being destroyed, the fungus is spread throughout the reticuloendothelial system accompanied by a transient fungemia.
In immunocompetent individuals, functional lymphocytes eventually activate the macrophages to kill the organism, containing the infection. However, in immunocompromised patients, this control mechanism fails, leading to progressive disseminated disease.
The tuberculosis similarity
The clinical and radiological similarities between histoplasmosis and tuberculosis are striking. Chronic cavitary histoplasmosis is characterized by pulmonary lesions that are often apical and resemble cavitary tuberculosis. Both diseases present with fever, night sweats, weight loss, productive cough, and progressive fatigue.
This similarity creates serious diagnostic challenges, especially in regions where tuberculosis is endemic. Patients may be mistakenly treated for TB when they actually have histoplasmosis, or vice versa. Even more concerning, the two infections can occur simultaneously in the same patient, particularly in immunocompromised individuals.
The radiological findings add to the confusion. Both diseases can show similar patterns on chest X-rays: upper lobe involvement, cavitary lesions, and calcified lymph nodes. The primary difference lies in laboratory diagnosis, which requires specific fungal cultures and antigen detection tests for histoplasmosis.
Why are systemic mycoses rare in India?
While systemic mycoses cause significant disease burden globally, they remain relatively uncommon in India compared to other regions. This geographic variation relates to the specific environmental conditions these fungi require.
Cryptococcus neoformans and Histoplasma capsulatum thrive in particular ecological niches. Histoplasmosis is endemic primarily in the Ohio and Mississippi River valleys in North America, parts of Central and South America, and some regions of Africa and Southeast Asia. The fungus requires specific soil conditions and temperature ranges that aren’t uniformly present in India.
Similarly, while Cryptococcus neoformans is found worldwide, the disease burden is highest in sub-Saharan Africa and among immunocompromised populations in the Americas. In 2019, a total of 20,061 confirmed coccidioidomycosis cases and 1,124 confirmed and probable histoplasmosis cases were reported to the CDC in the United States, demonstrating the geographic concentration of these infections.
However, this doesn’t mean these infections are absent from India. With increasing international travel, migration, and rising numbers of immunocompromised patients due to HIV and medical treatments, healthcare providers in India must remain vigilant for these infections, especially in patients returning from endemic areas or those with unexplained pneumonia-like symptoms that don’t respond to standard antibiotics.
The importance of early recognition
Because systemic mycoses can mimic common bacterial infections or tuberculosis, early recognition becomes critical for patient survival. The key is maintaining a high index of suspicion in appropriate clinical contexts: immunocompromised patients with respiratory symptoms, unexplained fever, or neurological manifestations should be evaluated for possible fungal infections.
Modern diagnostic tools have improved detection. Antigen detection tests for both Cryptococcus and Histoplasma can provide rapid results, often within hours, compared to traditional culture methods that may take weeks. These rapid tests have been shown to reduce mortality by enabling earlier treatment initiation.
Treatment typically involves antifungal medications such as amphotericin B for severe cases, followed by oral azole antifungals like fluconazole or itraconazole for maintenance therapy. The duration of treatment can range from months to years, depending on the severity of infection and the patient’s immune status.
What do you think? Given that systemic mycoses can so closely mimic tuberculosis in their presentation, how might healthcare facilities in TB-endemic regions improve their diagnostic protocols to avoid missing these fungal infections? As climate change potentially expands the geographic ranges of these environmental fungi, what preparedness measures should healthcare systems in currently non-endemic regions consider?
References
- https://dermnetnz.org/topics/skin-manifestations-of-systemic-mycoses
- https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3622-7
- https://www.cdc.gov/cryptococcosis/index.html
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3719228/
- https://www.asbmb.org/asbmb-today/science/092021/a-silent-killer-hiding-in-plain-sight
- https://journals.asm.org/doi/10.1128/cmr.00027-06
- https://actasdermo.org/en-cutaneous-involvement-in-deep-mycoses-articulo-S1578219016302414
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4681960/
- https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/histoplasma
- https://www.cdc.gov/mmwr/volumes/71/ss/ss7107a1.htm
Leave a Reply